September 2009
Problemy Terapii Monitorowanej;sep2009, Vol. 20 Issue 3, p217
Academic Journal
Cortistatin is a recently discovered neuropeptide related to somatostatin named after its predominantly cortical expression and ability to depress cortical activity. This is an endogenous peptide which shares similarity to somatostatin and binds all five somatostatin receptors and shares many farmacological and functional properties with somatostatin.Though similar in structure, somatostatin and cortistatin have been reported to have many different and even opposing effects.


Related Articles

  • Placing PRINCE in Perspective. Simpson Jr., Ross J. // JAMA: Journal of the American Medical Association;7/4/2001, Vol. 286 Issue 1, p91 

    Editorial. Comments on a study in this issue by Albert and colleagues on the results of the Pravastatin Inflammation/CRP Evaluation (PRINCE) study. Discussion of the study's results; View that the study is based on good scientific rationale, and adds prospective data to evidence that statins...

  • Cholesterol drug could be effective in treating prostate cancer.  // Urology Times;Nov2010, Vol. 38 Issue 12, p50 

    The article reports that according to a research published in the journal "European Urology," the statin drug rosuvastatin (Crestor) is found to be effective in treating prostate cancer.

  • Could statins be a real therapeutic option for the treatment of hepatitis C? Mendez-Navarro, Jorge; Avelar-Escobar, Giovanni; Gallardo-Cabrera, Victor E.; Malaguarnera, Michele; Vacante, Marco; Giordano, Maria; Malaguarnera, Mariano; Galvano, Fabio; Li Volti, Giovanni // Hepatitis Monthly;Jul2011, Vol. 11 Issue 7, p562 

    A letter to the editor and a response to the article "Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with a-interferon and ribavirin," by M. Malaguarnera and colleagues are presented.

  • Can statins prevent blood clots? James, Laura // GP: General Practitioner;4/10/2009, p20 

    The article focuses on the therapeutic effect of statin therapy in reducing the risk of fatal venous blood clots in Great Britain. Researchers found out that healthy men and women were less likely to suffer from venous thromboembolism (VTE) when given a dose of rosuvastatin daily. The study...

  • Atorvastatin does not slow cognitive decline in patients with mild to moderate probable Alzheimer's disease who are taking donepezil.  // Evidence Based Mental Health;Nov2010, Vol. 13 Issue 4, p117 

    The article discusses a study on whether atorvastatin improves cognition in patients with mild to moderate Alzheimer's disease (AD). The study included adults patients with mild to moderate probable AD with a mini-mental state examination (MMSE) score and taking donepezil for three of more than...

  • Antihiperlipidemik Tedavi Sonrası GeliÅŸen Rabdomiyoliz: Üç Olgu Sunumu. Ünal, Aydin; Sipahioglu, Murat Hayri; Tokgöz, Bülent; Akçakaya, Mesut; Coskun, Ramazan; Oymak, Oktay; Utas, Cengiz // Erciyes Medical Journal / Erciyes Tip Dergisi;2009 Supplement 1, pS01 

    Fibrates and statins are drugs which are frequently used in treatment of hyperlipidemia. However, there are some adverse effects of these drugs. These adverse effects are related to striated muscles, kidney, and liver. The most serious and potentially mortal adverse effect of these drugs is...

  • Current and Emerging Uses of Statins in Clinical Therapeutics: A Review. Davies, Jonathan T.; Delfino, Spencer F.; Feinberg, Chad E.; Johnson, Meghan F.; Nappi, Veronica L.; Olinger, Joshua T.; Schwab, Anthony P.; Swanson, Hollie I. // Lipid Insights;2016, Issue 9, p13 

    Statins, a class of cholesterol-lowering medications that inhibit 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, are commonly administered to treat atherosclerotic cardiovascular disease. Statin use may expand considerably given its potential for treating an array of cholesterolindependent...

  • Short-Term Effects of Ivabradine in Patients with Chronic Stable Ischemic Heart Disease. Zaky, Hosam; Elzein, Hind; Alsheikh-Ali, Alawi A.; Al-Mulla, Arif // Heart Views;Apr-Jun2013, Vol. 14 Issue 2, p53 

    Introduction: Ivabradine is a novel selective If current inhibitor with anti-ischemic and antianginal activity. Objectives: To assess the effect of the selective If current inhibitor ivabradine on heart rate, angina pectoris, and functional capacity in stable patients with chronic coronary...

  • Intensive Lipid Lowering and Coronary Plaque Regression.  // Clinical Cardiology Alert;Jan2012, Vol. 31 Issue 1, p1 

    The article discusses a study by Nicholls and colleagues which concluded that although maximal doses of two intensive statins- atorvastatin and rosuvastatin result in significant regression of coronary atherosclerosis, there is little difference between the two regimens. It mentions that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics